SHANGHAI, June 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the National Medical Products Administration (NMPA) of China has accepted the New Drug Application (NDA) for...
Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA )
Also on site :